1. Home
  2. CRCT vs ATAI Comparison

CRCT vs ATAI Comparison

Compare CRCT & ATAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cricut Inc.

CRCT

Cricut Inc.

HOLD

Current Price

$5.08

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

ATAI

ATAI Life Sciences N.V.

HOLD

Current Price

$4.38

Market Cap

1.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CRCT
ATAI
Founded
1969
2018
Country
United States
Netherlands
Employees
N/A
N/A
Industry
Wholesale Distributors
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.4B
IPO Year
2021
2021

Fundamental Metrics

Financial Performance
Metric
CRCT
ATAI
Price
$5.08
$4.38
Analyst Decision
Strong Sell
Strong Buy
Analyst Count
3
5
Target Price
$4.18
$14.00
AVG Volume (30 Days)
602.3K
4.3M
Earning Date
11-04-2025
11-12-2025
Dividend Yield
18.76%
N/A
EPS Growth
27.98
N/A
EPS
0.37
N/A
Revenue
$714,492,000.00
$3,018,000.00
Revenue This Year
N/A
$943.83
Revenue Next Year
N/A
N/A
P/E Ratio
$13.70
N/A
Revenue Growth
N/A
811.78
52 Week Low
$3.94
$1.15
52 Week High
$7.33
$6.75

Technical Indicators

Market Signals
Indicator
CRCT
ATAI
Relative Strength Index (RSI) 56.38 51.66
Support Level $4.65 $3.71
Resistance Level $4.90 $3.95
Average True Range (ATR) 0.14 0.23
MACD 0.07 0.08
Stochastic Oscillator 100.00 84.04

Price Performance

Historical Comparison
CRCT
ATAI

About CRCT Cricut Inc.

Cricut Inc designs and builds a creativity platform that enables users to turn ideas into professional-looking handmade goods. With its connected machines, design apps and accessories, and materials, the users create everything from personalized birthday cards, mugs and T-shirts to large-scale interior decorations. It has two segments including the Platform segment which derives revenue from monthly and annual subscription fees, purchases of digital content, and a minimal amount of the revenue allocated to unspecified future upgrades and enhancements related to the essential software and access to the Company's cloud-based services and Products segment which derives revenue from the sale of its connected machine hardware, and sale of craft, DIY, home decor products and extensions.

About ATAI ATAI Life Sciences N.V.

Atai Beckley NV is a clinical-stage biopharmaceutical company. It aims to develop mental health treatments to transform patient outcomes. The company's pipeline of psychedelic-based therapies includes VLS-01 and BPL-003 for the treatment-resistant depression (TRD) and EMP-01 (oral R-MDMA) for social anxiety disorder.

Share on Social Networks: